These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22227462)

  • 1. Chemical modulators working at pharmacological interface of target proteins.
    Jeon YH; Lee JY; Kim S
    Bioorg Med Chem; 2012 Mar; 20(6):1893-901. PubMed ID: 22227462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic applications of iminosugars: current perspectives and future opportunities.
    Horne G; Wilson FX
    Prog Med Chem; 2011; 50():135-76. PubMed ID: 21315930
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical constituents and biological activities of Adenium obesum (Forsk.) Roem. et Schult.
    Versiani MA; Ahmed SK; Ikram A; Ali ST; Yasmeen K; Faizi S
    Chem Biodivers; 2014 Feb; 11(2):171-80. PubMed ID: 24591309
    [No Abstract]   [Full Text] [Related]  

  • 5. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase.
    Axerio-Cilies P; See RH; Zoraghi R; Worral L; Lian T; Stoynov N; Jiang J; Kaur S; Jackson L; Gong H; Swayze R; Amandoron E; Kumar NS; Moreau A; Hsing M; Strynadka NC; McMaster WR; Finlay BB; Foster LJ; Young RN; Reiner NE; Cherkasov A
    ACS Chem Biol; 2012 Feb; 7(2):350-9. PubMed ID: 22066782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.
    Fernandez-Pol JA; Hamilton PD; Klos DJ
    Anticancer Res; 2001; 21(2A):931-57. PubMed ID: 11396187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New horizons for antiviral drug discovery from virus-host protein interaction networks.
    de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
    Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From protein interaction networks to novel therapeutic strategies.
    Jaeger S; Aloy P
    IUBMB Life; 2012 Jun; 64(6):529-37. PubMed ID: 22573601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain-selective targeting of BET proteins in cancer and immunological diseases.
    Petretich M; Demont EH; Grandi P
    Curr Opin Chem Biol; 2020 Aug; 57():184-193. PubMed ID: 32741705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties.
    Gifford JL; Hunter HN; Vogel HJ
    Cell Mol Life Sci; 2005 Nov; 62(22):2588-98. PubMed ID: 16261252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of Hsp90 inhibitors.
    Solit DB; Chiosis G
    Drug Discov Today; 2008 Jan; 13(1-2):38-43. PubMed ID: 18190862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
    Labro MT
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):319-40. PubMed ID: 22397566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preface for the COST Action Special Issue.
    Barea E; Müller J
    J Inorg Biochem; 2016 Jul; 160():59-60. PubMed ID: 27325582
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in developing small molecules targeting RNA.
    Guan L; Disney MD
    ACS Chem Biol; 2012 Jan; 7(1):73-86. PubMed ID: 22185671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IAP antagonists: promising candidates for cancer therapy.
    Mannhold R; Fulda S; Carosati E
    Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors.
    Voet A; Callewaert L; Ulens T; Vanderkelen L; Vanherreweghe JM; Michiels CW; De Maeyer M
    Biochem Biophys Res Commun; 2011 Feb; 405(4):527-32. PubMed ID: 21256115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.
    Oláh J; Szénási T; Lehotzky A; Norris V; Ovádi J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.